Investing
South Korean medical AI company made its debut on KOSDAQ, a trading board of Korea Exchange, for an IPO of 37.
The nearly 14-year-old company hopes to raise $75 million to support its implanted, closed-loop seizure prevention system.
Also: Dexcare raises $20 million for healthcare management platform and Heard closes seed funding round.
The new fund is country-agnostic, and it's looking for startups that aim to use digital tools to decrease mortality rates.
Investors have showered the New York company with $876 million to date.
The telehealth brand's annual revenue increased 80% YoY to $148.8 million in 2020, although its quarterly YoY growth dipped in Q4 compared to the months prior.
OMERS Growth Equity and Kaiser Permanente Group Trust led the round, with participation from McKesson Ventures and B Capital Group.
The company said that its platform is tracking more than 325 million patients' healthcare encounters.
The digital cardiology platform is designed to give patients a comprehensive, equitable and accessible way to manage hypertension and heart disease.
This Series B round brings the company's total funding to $223.5 million.